Len Schleifer
Co-founder, co-chair, and CEO of Regeneron Pharmaceuticals. Explains the company's focus on innovation, its pipeline of drugs, and its long-term vision.
Best podcasts with Len Schleifer
Ranked by the Snipd community
Jun 11, 2025 • 32min
Regeneron CEO on 23andMe & $275m in Margaritaville 6/11/25
Len Schleifer, Founder and CEO of Regeneron, discusses the potential acquisition of 23andMe, emphasizing the value of genetic data in drug development. He highlights how DNA insights can shape future therapies. Meanwhile, Robert Frank dives into the legal complexities surrounding Jimmy Buffett's $275 million estate amid fierce disputes between trustees. The episode tackles the intersection of healthcare innovation and personal legacies, revealing both the promise and challenges of navigating genetic information and wealth distribution.
Jan 15, 2025 • 44min
Mad Money w/ Jim Cramer 1/14/25
Robert Ford, Chairman and CEO of Abbott Labs, shares insights on the company’s innovative glucose monitoring technology and diversification strategies. Rob Davis of Merck discusses their promising oncology pipeline and the significance of Gardasil amidst challenges. Len Schleifer from Regeneron Pharmaceuticals highlights their focus on groundbreaking drug development and long-term vision in healthcare. Together, they explore the evolving landscape of the pharmaceutical industry and the impact of innovation on market dynamics.
